-
Eisai Releases Corporate Film “1 Percent, 1 Mission. Change the World.”
-
Video for World Cancer Day 2025
-
New Video on Eisai's Activities for Lymphatic Filariasis Elimination
World Neglected Tropical Diseases Day
-
Human Capital Report 2024
-
Value Creation Report 2024
-
World Alzheimer’s Month ー Life Goes On 2024
A documentary video portraying the daily life of people living with dementia (in Japanese)
-
February 6, 2025
Eisai Rated “A”, the Highest Rating by CDP in the Categories of Climate Change and Water Security
-
February 3, 2025
-
January 31, 2025
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
-
January 27, 2025
-
January 24, 2025
-
January 30, 2025
-
December 23, 2024
-
November 21, 2024
-
November 11, 2024
-
November 8, 2024
IR “Second Quarter Financial Report for the Fiscal Year Ending March 31, 2025”
-
October 3, 2024
EISAI NAMED AS ONE OF NEWSWEEK’S WORLD’S MOST TRUSTWORTHY COMPANIES 2024
-
June 21, 2024
Notification Regarding Revision of “Eisai Global Code of Conduct for Business Partners”
-
June 3, 2024
The Naito Museum of Pharmaceutical Science and Industry Listed as “Registered Museum”
-
April 8, 2024
-
October 13, 2023
Sustainability
32 countries 2.38 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of October 2024)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries